On: Truth Social losses $300M on Q1

[webninja]

ImmunityBio, Inc. (IBRX)

  -Market Cap: 4.80B
  -Revenue (ttm): 302,000
  -P/S Ratio: 15,892
  -Forward P/S 161

https://stockanalysis.com/stocks/ibrx/

Stunningly high price to sales ratio.